Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases

P. Gontero, F. Pisano, J. Palou, S. Joniau, M. Albersen, R. Colombo, A. Briganti, F. Pellucchi, OR. Faba, BW. van Rhijn, EF. van de Putte, M. Babjuk, HM. Fritsche, R. Mayr, P. Albers, G. Niegisch, J. Anract, A. Masson-Lecomte, A. De la Taille, M....

. 2020 ; 38 (8) : 1959-1968. [pub] 20191106

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020330

PURPOSE: Conflicting evidence exists on the complication rates after cystectomy following previous radiation (pRTC) with only a few available series. We aim to assess the complication rate of pRTC for abdominal-pelvic malignancies. METHODS: Patients treated with radical cystectomy following any previous history of RT and with available information on complications for a minimum of 1 year were included. Univariable and multivariable logistic regression models were used to assess the relationship between the variable parameters and the risk of any complication. RESULTS: 682 patients underwent pRTC after a previous RT (80.5% EBRT) for prostate, bladder (BC), gynecological or other cancers in 49.1%, 27.4%, 9.8% and 12.9%, respectively. Overall, 512 (75.1%) had at least one post-surgical complication, classified as Clavien ≥ 3 in 29.6% and Clavien V in 2.9%. At least one surgical complication occurred in 350 (51.3%), including bowel leakage in 6.2% and ureteric stricture in 9.4%. A medical complication was observed in 359 (52.6%) patients, with UTI/pyelonephritis being the most common (19%), followed by renal failure (12%). The majority of patients (86%) received an incontinent urinary diversion. In multivariable analysis adjusted for age, gender and type of RT, patients treated with RT for bladder cancer had a 1.7 times increased relative risk of experiencing any complication after RC compared to those with RT for prostate cancer (p = 0.023). The type of diversion (continent vs non-continent) did not influence the risk of complications. CONCLUSION: pRTC carries a high rate of major complications that dramatically exceeds the rates reported in RT-naïve RCs.

Academic Urology Unit University of Sheffield Sheffield UK

Department of Uro oncolgy Fundacio Puigvert University of Barcelona Barcelona Spain

Department of Urologic Sciences University of British Columbia Vancouver BC Canada

Department of Urology CHU Bichat Paris France

Department of Urology Heinrich Heine University Medical Faculty Düsseldorf Germany

Department of Urology Henri Mondor Academic Hospital Creteil France

Department of Urology Hôpital La Pitié Salpétrière Paris 6 University Paris France

Department of Urology Hôpital Saint Louis Université Paris Diderot Paris France

Department of Urology Kremlin Bicetre Hospital Assistance Publique Hôpitaux de Paris Paris France

Department of Urology Mayo Clinic Rochester USA

Department of Urology Medical University of Vienna Vienna Austria

Department of Urology Molinette Hospital University of Torino School of Medicine Turin Italy

Department of Urology Motol Hospital University of Praha Prague Czech Republic

Department of Urology N N Blokhin Russian Cancer Research Center Moscow Russia

Department of Urology Ospedale di Carpi Modena Modena Italy

Department of Urology Ospedale S Chiara Trento Italy

Department of Urology Rabin Medical Centre Tel Aviv Israel

Department of Urology Radboud University Nijmegen Medical Centre Nijmegen The Netherlands

Department of Urology Regensburg University Regensburg Germany

Department of Urology University Hospital Tübingen Tübingen Germany

Department of Urology University Medical Center Hamburg Eppendorf Hamburg Germany

Department of Urology University Medical Center Rostock Rostock Germany

Department of Urology University of Florence University Hospital of Florence Florence Italy

Department of Urology University of Miami Miller School of Medicine Miami FL USA

Department of Urology Weill Cornell Medical College New York USA

Netherland Cancer Institute Amsterdam The Netherlands

Oncologic and Reconstructive Urology Department of Urology University Hospitals Leuven Louvain Belgium

Unit of Urology Division of Oncology URI IRCCS Ospedale San Raffaele Milan Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020330
003      
CZ-PrNML
005      
20210830102041.0
007      
ta
008      
210728s2020 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00345-019-02982-6 $2 doi
035    __
$a (PubMed)31691084
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Gontero, Paolo $u Department of Urology, Molinette Hospital, University of Torino School of Medicine, Turin, Italy
245    10
$a Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases / $c P. Gontero, F. Pisano, J. Palou, S. Joniau, M. Albersen, R. Colombo, A. Briganti, F. Pellucchi, OR. Faba, BW. van Rhijn, EF. van de Putte, M. Babjuk, HM. Fritsche, R. Mayr, P. Albers, G. Niegisch, J. Anract, A. Masson-Lecomte, A. De la Taille, M. Roupret, B. Peyronnet, T. Cai, AJ. Witjes, M. Bruins, J. Baniel, R. Mano, A. Lapini, F. Sessa, J. Irani, M. Brausi, A. Stenzl, JR. Karnes, D. Scherr, P. O'Malley, B. Taylor, SF. Shariat, P. Black, H. Abdi, VB. Matveev, O. Samuseva, D. Parekh, M. Gonzalgo, MW. Vetterlein, A. Aziz, M. Fisch, J. Catto, KH. Pang, E. Xylinas, M. Rink, Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology
520    9_
$a PURPOSE: Conflicting evidence exists on the complication rates after cystectomy following previous radiation (pRTC) with only a few available series. We aim to assess the complication rate of pRTC for abdominal-pelvic malignancies. METHODS: Patients treated with radical cystectomy following any previous history of RT and with available information on complications for a minimum of 1 year were included. Univariable and multivariable logistic regression models were used to assess the relationship between the variable parameters and the risk of any complication. RESULTS: 682 patients underwent pRTC after a previous RT (80.5% EBRT) for prostate, bladder (BC), gynecological or other cancers in 49.1%, 27.4%, 9.8% and 12.9%, respectively. Overall, 512 (75.1%) had at least one post-surgical complication, classified as Clavien ≥ 3 in 29.6% and Clavien V in 2.9%. At least one surgical complication occurred in 350 (51.3%), including bowel leakage in 6.2% and ureteric stricture in 9.4%. A medical complication was observed in 359 (52.6%) patients, with UTI/pyelonephritis being the most common (19%), followed by renal failure (12%). The majority of patients (86%) received an incontinent urinary diversion. In multivariable analysis adjusted for age, gender and type of RT, patients treated with RT for bladder cancer had a 1.7 times increased relative risk of experiencing any complication after RC compared to those with RT for prostate cancer (p = 0.023). The type of diversion (continent vs non-continent) did not influence the risk of complications. CONCLUSION: pRTC carries a high rate of major complications that dramatically exceeds the rates reported in RT-naïve RCs.
650    _2
$a nádory břicha $x radioterapie $7 D000008
650    _2
$a senioři $7 D000368
650    12
$a cystektomie $7 D015653
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a internacionalita $7 D038622
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pooperační komplikace $x epidemiologie $7 D011183
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a močový měchýř $x účinky záření $7 D001743
650    _2
$a nádory močového měchýře $x chirurgie $7 D001749
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Pisano, Francesca $u Department of Urology, Molinette Hospital, University of Torino School of Medicine, Turin, Italy. francescapisano85@gmail.com $u Department of Uro-oncolgy, Fundacio Puigvert, University of Barcelona, Barcelona, Spain. francescapisano85@gmail.com
700    1_
$a Palou, Joan $u Department of Uro-oncolgy, Fundacio Puigvert, University of Barcelona, Barcelona, Spain
700    1_
$a Joniau, Steven $u Oncologic and Reconstructive Urology, Department of Urology, University Hospitals Leuven, Louvain, Belgium
700    1_
$a Albersen, Maarten $u Oncologic and Reconstructive Urology, Department of Urology, University Hospitals Leuven, Louvain, Belgium
700    1_
$a Colombo, Renzo $u Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy
700    1_
$a Briganti, Alberto $u Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy
700    1_
$a Pellucchi, Federico $u Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy
700    1_
$a Faba, Oscar Rodriguez $u Department of Uro-oncolgy, Fundacio Puigvert, University of Barcelona, Barcelona, Spain
700    1_
$a van Rhijn, Bas W $u Netherland Cancer Institute, Amsterdam, The Netherlands
700    1_
$a van de Putte, Elies Fransen $u Netherland Cancer Institute, Amsterdam, The Netherlands
700    1_
$a Babjuk, Marko $u Department of Urology, Motol Hospital, University of Praha, Prague, Czech Republic
700    1_
$a Fritsche, Hanz Martin $u Department of Urology, Regensburg University, Regensburg, Germany
700    1_
$a Mayr, Roman $u Department of Urology, Regensburg University, Regensburg, Germany
700    1_
$a Albers, Peter $u Department of Urology, Heinrich-Heine-University, Medical Faculty, Düsseldorf, Germany
700    1_
$a Niegisch, Gunter $u Department of Urology, Heinrich-Heine-University, Medical Faculty, Düsseldorf, Germany
700    1_
$a Anract, Julien $u Department of Urology, CHU Bichat, Paris, France
700    1_
$a Masson-Lecomte, Alexandra $u Department of Urology, Hôpital Saint-Louis, Université Paris-Diderot, Paris, France
700    1_
$a De la Taille, Alexandre $u Department of Urology, Henri Mondor Academic Hospital, Creteil, France
700    1_
$a Roupret, Morgan $u Department of Urology, Hôpital La Pitié-Salpétrière, Paris 6 University, Paris, France
700    1_
$a Peyronnet, Benoit $u Department of Urology, Hôpital La Pitié-Salpétrière, Paris 6 University, Paris, France
700    1_
$a Cai, Tomaso $u Department of Urology, Ospedale S. Chiara, Trento, Italy
700    1_
$a Witjes, Alfred J $u Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
700    1_
$a Bruins, Max $u Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
700    1_
$a Baniel, Jack $u Department of Urology, Rabin Medical Centre, Tel Aviv, Israel
700    1_
$a Mano, Roy $u Department of Urology, Rabin Medical Centre, Tel Aviv, Israel
700    1_
$a Lapini, Alberto $u Department of Urology, University of Florence, University Hospital of Florence, Florence, Italy
700    1_
$a Sessa, Francesco $u Department of Urology, University of Florence, University Hospital of Florence, Florence, Italy
700    1_
$a Irani, Jaques $u Department of Urology, Kremlin-Bicetre Hospital, Assistance Publique Hôpitaux de Paris, Paris, France
700    1_
$a Brausi, Maurizio $u Department of Urology, Ospedale di Carpi-Modena, Modena, Italy
700    1_
$a Stenzl, Arnulf $u Department of Urology, University Hospital Tübingen, Tübingen, Germany
700    1_
$a Karnes, Jeffrey R $u Department of Urology, Mayo Clinic, Rochester, USA
700    1_
$a Scherr, Douglas $u Department of Urology, Weill Cornell Medical College, New York, USA
700    1_
$a O'Malley, Padraic $u Department of Urology, Weill Cornell Medical College, New York, USA
700    1_
$a Taylor, Benjamin $u Department of Urology, Weill Cornell Medical College, New York, USA
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Medical University of Vienna, Vienna, Austria
700    1_
$a Black, Peter $u Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada
700    1_
$a Abdi, Hamidreza $u Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada
700    1_
$a Matveev, Vsevolod B $u Department of Urology, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia
700    1_
$a Samuseva, Olga $u Department of Urology, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia
700    1_
$a Parekh, Dipen $u Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA
700    1_
$a Gonzalgo, Mark $u Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA
700    1_
$a Vetterlein, Malte W $u Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Aziz, Atiqullah $u Department of Urology, University Medical Center Rostock, Rostock, Germany
700    1_
$a Fisch, Margit $u Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Catto, James $u Academic Urology Unit, University of Sheffield, Sheffield, UK
700    1_
$a Pang, Karl H $u Academic Urology Unit, University of Sheffield, Sheffield, UK
700    1_
$a Xylinas, Evanguelos $u Department of Urology, CHU Bichat, Paris, France
700    1_
$a Rink, Michael $u Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
710    2_
$a Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology
773    0_
$w MED00004739 $t World journal of urology $x 1433-8726 $g Roč. 38, č. 8 (2020), s. 1959-1968
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31691084 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830102042 $b ABA008
999    __
$a ok $b bmc $g 1690999 $s 1140776
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 38 $c 8 $d 1959-1968 $e 20191106 $i 1433-8726 $m World journal of urology $n World J Urol $x MED00004739
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...